MENU
+Compare
QNCX
Stock ticker: NASDAQ
AS OF
Oct 14 closing price
Price
$1.94
Change
-$0.02 (-1.02%)
Capitalization
103.94M

QNCX Quince Therapeutics Forecast, Technical & Fundamental Analysis

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more

Industry: #Biotechnology
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for QNCX with price predictions
Oct 08, 2025

QNCX in upward trend: 10-day moving average crossed above 50-day moving average on October 06, 2025

The 10-day moving average for QNCX crossed bullishly above the 50-day moving average on October 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2025. You may want to consider a long position or call options on QNCX as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for QNCX just turned positive on September 12, 2025. Looking at past instances where QNCX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

QNCX moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where QNCX advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 158 cases where QNCX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for QNCX moved out of overbought territory on October 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

QNCX broke above its upper Bollinger Band on October 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. QNCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.857) is normal, around the industry mean (23.456). P/E Ratio (0.000) is within average values for comparable stocks, (54.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.164). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (347.799).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNCX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

QNCX is expected to report earnings to fall 36.47% to -21 cents per share on November 13

Quince Therapeutics QNCX Stock Earnings Reports
Q3'25
Est.
$-0.22
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.15
Q4'24
Missed
by $0.10
Q3'24
Missed
by $0.03
The last earnings report on August 11 showed earnings per share of -34 cents, missing the estimate of -25 cents. With 200.67K shares outstanding, the current market capitalization sits at 103.94M.
A.I. Advisor
published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BJWTF0.31N/A
N/A
Beijing Enterprises Water Group, Ltd.
GJNSF17.52N/A
N/A
Gjensidige Forsikring Asa
GRPRF0.70N/A
N/A
GRUPO ROTOPLAS S A B
VIIQ0.20N/A
N/A
VisitIQ Corp.
BLMWF0.91-0.03
-2.78%
BluMetric Environmental, Inc.

QNCX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+4.81%
MNPR - QNCX
33%
Loosely correlated
+16.20%
KOD - QNCX
28%
Poorly correlated
-2.27%
SRZN - QNCX
24%
Poorly correlated
+0.39%
LQDA - QNCX
24%
Poorly correlated
+2.50%
MDXG - QNCX
24%
Poorly correlated
-0.61%
More